{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:04:58Z","timestamp":1792112698175,"version":"4.4.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.diabres.2026.113383","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:20:13Z","timestamp":1781886013000},"page":"113383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gut\u2013pancreas\u2013metabolism axis: emerging anti-diabetic roles of gut-derived bioactive molecules"],"prefix":"10.1016","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5328-8606","authenticated-orcid":false,"given":"Shakir","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Km.","family":"Kahkasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.diabres.2026.113383_b0005","article-title":"Gut microbiota: a new target for T2DM prevention and treatment","volume":"11","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113383_b0010","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/foods11081077","article-title":"The concept of postbiotics","volume":"11","author":"Vinderola","year":"2022","journal-title":"Foods"},{"issue":"8","key":"10.1016\/j.diabres.2026.113383_b0015","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/oby.24329","article-title":"Long-acting PYY3\u201336 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies","volume":"33","author":"Wulff","year":"2025","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"10.1016\/j.diabres.2026.113383_b0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41575-025-01058-8","article-title":"Metabolic diseases in the East Asian populations","volume":"22","author":"Sun","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.diabres.2026.113383_b0025","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/nu17060948","article-title":"Gut microbiota modulation through Mediterranean diet foods: implications for human health","volume":"17","author":"Perrone","year":"2025","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.diabres.2026.113383_b0030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s42255-023-00811-0","article-title":"The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets","volume":"5","author":"El","year":"2023","journal-title":"Nat Metab"},{"issue":"5","key":"10.1016\/j.diabres.2026.113383_b0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41575-023-00891-z","article-title":"Effects of dietary fibre on metabolic health and obesity","volume":"21","author":"Deehan","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"16","key":"10.1016\/j.diabres.2026.113383_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/nu16162668","article-title":"Effect of mutant and engineered high-acetate-producing Saccharomyces cerevisiae var. boulardii strains in dextran sodium sulphate-induced colitis","volume":"16","author":"Deleu","year":"2024","journal-title":"Nutrients"},{"issue":"24","key":"10.1016\/j.diabres.2026.113383_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413656","article-title":"Pharmacological mechanisms of bile acids targeting the farnesoid X receptor","volume":"25","author":"Qi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113383_b0050","unstructured":"Cheng L. Exploring the interaction between the human microbiota and infections. Karolinska Institutet (Sweden); 2022. https:\/\/hdl.handle.net\/10616\/48253."},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cmet.2025.10.011","article-title":"From microbiome to metabolism: Bridging a two-decade translational gap","volume":"38","author":"Van Hul","year":"2026","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.diabres.2026.113383_b0060","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s00125-024-06144-1","article-title":"Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials","volume":"67","author":"Karagiannis","year":"2024","journal-title":"Diabetologia"},{"issue":"46","key":"10.1016\/j.diabres.2026.113383_b0065","doi-asserted-by":"crossref","first-page":"25767","DOI":"10.1021\/acs.jafc.4c08671","article-title":"Lactiplantibacillus plantarum Y44 complex fermented milk regulates lipid metabolism in mice fed with high-fat diet by modulating gut microbiota","volume":"72","author":"Gao","year":"2024","journal-title":"J Agric Food Chem"},{"issue":"26","key":"10.1016\/j.diabres.2026.113383_b0070","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1080\/10408398.2022.2056727","article-title":"Postbiotics as the new frontier in food and pharmaceutical research","volume":"63","author":"Sabahi","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"7","key":"10.1016\/j.diabres.2026.113383_b0075","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/s41591-025-03719-2","article-title":"Individual variations in glycemic responses to carbohydrates and underlying metabolic physiology","volume":"31","author":"Wu","year":"2025","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.diabres.2026.113383_b0080","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00125-023-05956-x","article-title":"Incretin hormones and type 2 diabetes","volume":"66","author":"Nauck","year":"2023","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.diabres.2026.113383_b0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/gutjnl-2025-335610","article-title":"Gut microbiota and atherosclerosis","volume":"75","author":"Fusco","year":"2026","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.diabres.2026.113383_b0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/ijms23031105","article-title":"Gut microbiota and short chain fatty acids: implications in glucose homeostasis","volume":"23","author":"Portincasa","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.diabres.2026.113383_b0095","doi-asserted-by":"crossref","first-page":"15094","DOI":"10.3390\/ijms242015094","article-title":"The role of short-chain fatty acids in microbiota\u2013gut\u2013brain cross-talk with a focus on amyotrophic lateral sclerosis: a systematic review","volume":"24","author":"Mo\u021b\u0103\u021b\u0103ianu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.diabres.2026.113383_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/nu14132559","article-title":"Effects of dietary fibers on short-chain fatty acids and gut microbiota composition in healthy adults: a systematic review","volume":"14","author":"Vinelli","year":"2022","journal-title":"Nutrients"},{"issue":"90","key":"10.1016\/j.diabres.2026.113383_b0105","article-title":"Personalized nutrition and machine-learning: exploring the scope of continuous glucose monitoring in healthy individuals in uncontrolled settings","volume":"1","author":"Zignoli","year":"2024","journal-title":"Biomed Signal Process Control"},{"issue":"3","key":"10.1016\/j.diabres.2026.113383_b0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10654-022-00960-8","article-title":"Estimates and forecasts on the burden of prediabetes and diabetes in adult and elderly population in Turkiye","volume":"38","author":"Satman","year":"2023","journal-title":"Eur J Epidemiol"},{"issue":"27","key":"10.1016\/j.diabres.2026.113383_b0115","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1080\/10408398.2024.2409956","article-title":"Effects of probiotics, prebiotics, and synbiotics on cardiometabolic risk factors in children and adolescents with overweight or obesity: a systematic review and Bayesian network meta-analysis","volume":"65","author":"Zhang","year":"2025","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/ph18010055","article-title":"The gut microbiota-related antihyperglycemic effect of metformin","volume":"18","author":"Szymczak-Pajor","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"17","key":"10.1016\/j.diabres.2026.113383_b0125","doi-asserted-by":"crossref","first-page":"8766","DOI":"10.1039\/D1FO03204F","article-title":"Effects of oligosaccharides on the markers of glycemic control: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"An","year":"2022","journal-title":"Food Funct"},{"issue":"8","key":"10.1016\/j.diabres.2026.113383_b0130","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41564-025-02064-x","article-title":"Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism","volume":"10","author":"Fan","year":"2025","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.diabres.2026.113383_b0135","first-page":"3","article-title":"Global trends in diabetes complications","volume":"66","author":"Harding","year":"2023","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.diabres.2026.113383_b0145","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.3390\/ijms25105441","article-title":"Postbiotics as metabolites and their biotherapeutic potential","volume":"25","author":"Hijov\u00e1","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113383_b0150","doi-asserted-by":"crossref","unstructured":"Tuohy K, Vaughan EE, Harthoorn LF, Blaak EE, Burnet PW, Busetti A, et al. Prebiotics in food and dietary supplements: a roadmap to EU health claims. doi: 10.1080\/19490976.2024.2428848.","DOI":"10.1080\/19490976.2024.2428848"},{"issue":"3","key":"10.1016\/j.diabres.2026.113383_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms14030540","article-title":"Interactions between plant proteins and gut microbiota as determinants of intestinal health","volume":"14","author":"Szyd\u0142owska","year":"2026","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.diabres.2026.113383_b0160","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4239\/wjd.v12.i8.1146","article-title":"Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products","volume":"12","author":"Xia","year":"2021","journal-title":"World J Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2026.113383_b0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/biomedicines13040911","article-title":"Gut microbiota in heart failure-the role of inflammation","volume":"13","author":"Fountoulakis","year":"2025","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.diabres.2026.113383_b0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41574-024-01067-8","article-title":"Bile acid metabolism in type 2 diabetes mellitus","volume":"21","author":"Cadena Sandoval","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes global burden of disease and forecasted trends","volume":"10","author":"Abdul Basith Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"issue":"6","key":"10.1016\/j.diabres.2026.113383_b0180","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41591-020-0934-0","article-title":"Human postprandial responses to food and potential for precision nutrition","volume":"26","author":"Berry","year":"2020","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.diabres.2026.113383_b0185","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1039\/D1FO02033A","article-title":"Main drivers of (poly) phenol effects on human health: metabolite production and\/or gut microbiota-associated metabotypes?","volume":"12","author":"Iglesias-Aguirre","year":"2021","journal-title":"Food Funct"},{"issue":"5","key":"10.1016\/j.diabres.2026.113383_b0190","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/biomedicines11051362","article-title":"Effect of semaglutide on subclinical atherosclerosis and cardiometabolic compensation: a real-world study in patients with type 2 diabetes","volume":"11","author":"Patti","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.diabres.2026.113383_b0195","article-title":"Intrinsic chicory root fibers modulate colonic microbial butyrate-producing pathways and improve insulin sensitivity in individuals with obesity","volume":"6","author":"Omary","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.diabres.2026.113383_b0200","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2147\/DMSO.S455026","article-title":"The regulation role of the gut-islets axis in diabetes","volume":"31","author":"Yang","year":"2024","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"issue":"5","key":"10.1016\/j.diabres.2026.113383_b0205","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11606-021-07157-x","article-title":"HbA1c-triggered endocrinology electronic consultation for type 2 diabetes management","volume":"37","author":"Oseran","year":"2022","journal-title":"J Gen Intern Med."},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0210","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"6706","key":"10.1016\/j.diabres.2026.113383_b0215","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.adn4128","article-title":"The benefits of GLP-1 drugs beyond obesity","volume":"385","author":"Drucker","year":"2024","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"15","key":"10.1016\/j.diabres.2026.113383_b0225","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3390\/foods14152670","article-title":"Dietary fiber as prebiotics: a mitigation strategy for metabolic diseases","volume":"14","author":"Gao","year":"2025","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/clinbioenerg2010005","article-title":"The bioenergetic architecture of metabolic regulation: from gut\u2013brain signalling to next-generation peptide pharmacology","volume":"2","author":"Rega","year":"2026","journal-title":"Clin Bioenerget"},{"issue":"5","key":"10.1016\/j.diabres.2026.113383_b0235","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/endrev\/bnac004","article-title":"The metabolic role and therapeutic potential of the microbiome","volume":"43","author":"Olofsson","year":"2022","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.diabres.2026.113383_b0240","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab065","article-title":"The role of incretins on insulin function and glucose homeostasis","volume":"162","author":"Holst","year":"2021","journal-title":"Endocrinology."},{"issue":"16","key":"10.1016\/j.diabres.2026.113383_b0245","article-title":"Gut microbiota and its metabolites regulate insulin resistance: traditional Chinese medicine insights for T2DM","volume":"19","author":"Liu","year":"2025","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.diabres.2026.113383_b0250","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500295R","article-title":"Multifaceted role of microbiota\u2010derived indole\u20103\u2010acetic acid in human diseases and its potential clinical application","volume":"39","author":"Shaheen","year":"2025","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.diabres.2026.113383_b0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113383_b0260","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/biology14121705","article-title":"Dietary polyphenols-gut microbiota interactions: intervention strategies and metabolic regulation for intestinal diseases","volume":"14","author":"Li","year":"2025","journal-title":"Biology"},{"issue":"10","key":"10.1016\/j.diabres.2026.113383_b0265","article-title":"Enhancing intestinal barrier efficiency: a novel metabolic diseases therapy","volume":"2","author":"Zhang","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.diabres.2026.113383_b0270","article-title":"Probiotics, prebiotics, synbiotics, and FMT for glycemic control: a systematic review of clinical efficacy and mechanistic readouts in type 2 diabetes and related dysglycemia","volume":"12","author":"Shalbaf","year":"2025","journal-title":"Metabolism Open"},{"issue":"2","key":"10.1016\/j.diabres.2026.113383_b0275","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1007\/s12602-025-10644-w","article-title":"Effects of probiotic and synbiotic supplementation on glycemic indices in adult individuals with prediabetes and type 2 diabetes mellitus: a grade-assessed systematic review and dose\u2013response meta-analysis of RCTs","volume":"18","author":"Setayesh","year":"2026","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"7","key":"10.1016\/j.diabres.2026.113383_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071398","article-title":"Gut\u2013liver\u2013pancreas axis crosstalk in health and disease: from the role of microbial metabolites to innovative microbiota manipulating strategies","volume":"12","author":"Marroncini","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.diabres.2026.113383_b0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/diabetology7030046","article-title":"Incretin-based multi-agonist therapies for type 2 diabetes mellitus and obesity: mechanisms, clinical efficacy, and future directions","volume":"7","author":"Podder","year":"2026","journal-title":"Diabetology"},{"issue":"12","key":"10.1016\/j.diabres.2026.113383_b0290","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-093120","article-title":"Intestinal microbiota transplant prior to allogeneic stem cell transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial","volume":"14","author":"Mullish","year":"2024","journal-title":"BMJ Open"},{"issue":"13","key":"10.1016\/j.diabres.2026.113383_b0295","doi-asserted-by":"crossref","first-page":"18408","DOI":"10.1007\/s11356-022-18534-2","article-title":"Role and mechanism (s) of incretin-dependent therapies for treating diabetes mellitus","volume":"29","author":"Nasr","year":"2022","journal-title":"Environ Sci Pollut Res"},{"issue":"7","key":"10.1016\/j.diabres.2026.113383_b0300","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/HYPERTENSIONAHA.123.22575","article-title":"Recommendations for the use of dietary fiber to improve blood pressure control","volume":"81","author":"Jama","year":"2024","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.diabres.2026.113383_b0305","article-title":"Probiotics and their role in the management of type 2 diabetes mellitus (short-term versus long-term effect): a systematic review and meta-analysis","volume":"15","author":"Ayesha","year":"2023","journal-title":"Cureus."},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00125-020-05295-1","article-title":"The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis","volume":"64","author":"Bock","year":"2021","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0315","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2185034","article-title":"Emerging issues in probiotic safety: 2023 perspectives","volume":"15","author":"Merenstein","year":"2023","journal-title":"Gut Microbes"},{"issue":"183","key":"10.1016\/j.diabres.2026.113383_b0320","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"1","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s43586-024-00376-6","article-title":"Analysis of metagenomic data","volume":"5","author":"Liu","year":"2025","journal-title":"Nat Rev Methods Primers"},{"issue":"4","key":"10.1016\/j.diabres.2026.113383_b0330","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s42255-024-00986-0","article-title":"Metabolic messengers: thyroid hormones","volume":"6","author":"Sinha","year":"2024","journal-title":"Nat Metab"},{"issue":"11","key":"10.1016\/j.diabres.2026.113383_b0335","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.3390\/jcm14113673","article-title":"A review of the influence of prebiotics, probiotics, synbiotics, and postbiotics on the human gut microbiome and intestinal integrity","volume":"14","author":"Smolinska","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2026.113383_b0340","doi-asserted-by":"crossref","unstructured":"Islam A, Singh A, Ahmad A, Akhtar J, Ahmad U, Khan MI, et al. Exploring gut microbiota as therapeutic target to maintain metabolic health. In: Synbiotics in metabolic disorders. CRC Press; 2024. p. 68\u201389.","DOI":"10.1201\/9781032702438-5"},{"issue":"16","key":"10.1016\/j.diabres.2026.113383_b0345","article-title":"Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers","volume":"17","author":"Zeng","year":"2025","journal-title":"Front Microbiol"},{"issue":"16","key":"10.1016\/j.diabres.2026.113383_b0350","article-title":"Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes","volume":"14","author":"Song","year":"2025","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113383_b0355","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tim.2022.10.003","article-title":"Gut microbiota\u2013bile acid\u2013skeletal muscle axis","volume":"31","author":"Mancin","year":"2023","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113383_b0360","doi-asserted-by":"crossref","first-page":"24580","DOI":"10.1038\/s41598-024-75477-z","article-title":"Evaluation of inter-and intra-variability in gut health markers in healthy adults using an optimised faecal sampling and processing method","volume":"14","author":"Kruger","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.diabres.2026.113383_b0365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/nu18020290","article-title":"Personalized nutrition through the gut microbiome in metabolic syndrome and related comorbidities","volume":"18","author":"Plaza-Diaz","year":"2026","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.diabres.2026.113383_b0370","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41430-021-00991-6","article-title":"RETRACTED ARTICLE: role of the gut microbiome in chronic diseases: a narrative review","volume":"76","author":"Vijay","year":"2022","journal-title":"Eur J Clin Nutr"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:03:21Z","timestamp":1783458201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726003037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":74,"alternative-id":["S0168822726003037"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113383","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut\u2013pancreas\u2013metabolism axis: emerging anti-diabetic roles of gut-derived bioactive molecules","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113383"}}